Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06801717 · ClinicalTrials.gov registry record · NA
Rosacea Radiofrequency Microneedling
A NA study of Rosacea, Papulopustular and Rosacea, Erythematotelangiectatic, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06801717: Recruiting NA study of Rosacea, Papulopustular and Rosacea, Erythematotelangiectatic, sponsored by University of Miami.
NCT06801717 is a NA study of Rosacea, Papulopustular and Rosacea, Erythematotelangiectatic that is actively recruiting participants, run by University of Miami. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06801717, a NA study of Rosacea, Papulopustular and Rosacea, Erythematotelangiectatic, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for combination treatment of radiofrequency microneedling with the 532 nm KTP laser, and (3) identify potential novel therapeutic strategies for the treatment of rosacea.
Primary Outcome
Score range from 0 (clear skin) to 4 (severe erythema). Lower scores indicate less rosacea severity as assessed by the CEA scale.
Conditions Studied
Interventions
- DEVICE KTP Laser Therapy
- DEVICE Radiofrequency microneedling
Study Locations (1)
Florida
- University of Miami Dermatology Miami Beach Clinic - Miami Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What NCT06801717 shows while recruiting
NCT06801717 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Rosacea, Papulopustular appearing as the primary indexed condition, and to 2 interventions - of which KTP Laser Therapy is the first listed.
NCT06801717 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06801717 about?
NCT06801717 is a clinical study titled "Rosacea Radiofrequency Microneedling". There are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic and or papulopustular rosacea, (2) to determine the potential for combination treatment of radiofrequency microneedling with the 532 nm KTP...
What is the current status of trial NCT06801717?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-01. Estimated completion is 2026-04-01.
What conditions does trial NCT06801717 study?
This clinical trial studies the following conditions: Rosacea, Papulopustular, Rosacea, Erythematotelangiectatic.
What interventions are being tested in trial NCT06801717?
The interventions under investigation include: KTP Laser Therapy (DEVICE), Radiofrequency microneedling (DEVICE).
Who is sponsoring clinical trial NCT06801717?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06801717 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06801717's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI